Cernostics, a Pittsburgh, PA-based diagnostics company focused on delivering better cancer diagnosis and prognosis through a unique approach to tissue analysis has raised $2.5 million in Series A funding led by Illumina Ventures. With the recent investment from Illumina Ventures, Cernostics has raised a total of $13 million, including investments from UPMC Enterprises, Novitas Capital, Geisinger Health System, the Pittsburgh Life Sciences Greenhouse, and Ben Franklin Technology Partners of
Read More
Cernostics
Backed by UPMC, Cancer Diagnostics Startup Cernostics Lands $5M
Cernostics, a Pittsburgh, PA-based cancer diagnostics startup has raised $5 million in funding led by UPMC Enterprises, UPMC's venture capital arm with participation from Novitas Capital. The company plans to utilize the funding to accelerate the introduction of new diagnostic test for people with an esophageal condition called Barrett’s Esophagus that can lead to cancer. The latest round brings the company's total funding to date to $12.4M. Founded in 2008, Cernostics is an oncology diagnostics
Read More